No Direct Drug Interaction Between Testosterone and Carvedilol Causing Fever and Nausea
There is no documented drug interaction between testosterone and carvedilol (Coreg) that causes fever and nausea. These symptoms are not listed as adverse effects of combining these medications in FDA labeling or clinical guidelines.
Evidence from FDA Drug Labeling
The FDA label for Coreg 1 provides comprehensive adverse event data and drug interaction information. Notably absent from this extensive documentation is any mention of testosterone as an interacting drug or fever and nausea as combination-specific adverse effects. The Coreg label specifically lists drug interactions with:
- CYP2D6 inhibitors (quinidine, fluoxetine, paroxetine)
- Hypotensive agents (reserpine, clonidine)
- Cyclosporine
- Digoxin
- Rifampin and cimetidine
- Amiodarone
Testosterone does not appear in this list 1.
Individual Drug Side Effect Profiles
Carvedilol Adverse Effects
Common adverse effects of carvedilol include dizziness (6-32%), bradycardia (2-10%), hypotension (3-14%), fatigue (11-24%), and diarrhea (2-12%) 1. Nausea occurs in 4-9% of patients, but fever is not listed as a recognized adverse effect of carvedilol monotherapy 1.
Testosterone Adverse Effects
Testosterone replacement therapy causes skin reactions (erythema, pruritus in up to 66% with patches), injection site reactions, fluid retention, breast tenderness, and rarely hypertension 2. Neither fever nor nausea are documented as common adverse effects of testosterone therapy 2, 3.
Research Context
Interestingly, research actually suggests carvedilol may have protective effects on testicular function. Studies demonstrate carvedilol can enhance testosterone production and protect against testicular damage in animal models 4, 5. This further supports the absence of a negative pharmacological interaction between these agents.
Clinical Interpretation
If a patient on both testosterone and carvedilol develops fever and nausea, look for alternative explanations:
- Infection (fever with nausea suggests infectious etiology)
- Gastrointestinal pathology unrelated to medications
- Other concurrent medications not mentioned
- Carvedilol-related nausea (4-9% incidence) coinciding with unrelated febrile illness
- Testosterone injection site infection (if using intramuscular formulation)
The temporal relationship of symptom onset to medication initiation or dose changes would be critical to assess, but even with temporal correlation, these symptoms do not represent a known pharmacodynamic or pharmacokinetic interaction between testosterone and carvedilol.